PanoramaXP test

The PanoramaXP test is currently one of the most reliable, safe and accurate screening tests for chromosomal diseases based on a DNA single nucleotide polymorphism, which makes it possible to detect 5 important microdeletions in the mother's venous blood in addition to Down, Edwards, and Patau syndrome and triploid syndrome, all of which strongly affect the child's health. They cause mental retardation, heart and breathing problems, immune and nutritional problems, and other disorders that may require immediate postnatal intervention.

The combined incidence of 5 microdeletions detected by the PanoramaXP test is approximately 1 in every 1000 births, which is more common in young mothers than Down syndrome.

The incidence of microdeletions does not depend on the age of the woman. Conventional NIPT tests are more sensitive in identifying chromosomal disorders in older women, and therefore there are more screening-negative results (meaning that the child is sick, but the NIPT test shows a low risk). The advantage of the Panorama XP test over other NIPT tests in particular is the fact that its sensitivity in recognizing chromosomal diseases does not depend on the age of the woman, and is equally good for both younger and older pregnant women.

The PanoramaXP test cannot be performed in a multiple pregnancy.

Performing the PanoramaXP test.
 

• For the PanoramaXP test, only the mother's venous blood analysis is required.
• The PanoramaXP test is carried out for those whose pregnancy has lasted for at least 9 full weeks (9 weeks + 0 days). If you would like to know the duration of your pregnancy, please visit our  pregnancy calculator.  
• With the test, it is also possible to find out the sex of the fetus if you wish.
• The results for the PanoramaXP test are received within 14 days of the blood test.

The price of the test include a very early ultrasound examination of fetal developmental defects.

Very early fetal developmental ultrasound with the  NIPT tests is the most accurate combined prenatal screening method for the early detection of children with chromosomal diseases. The purpose of an ultrasound scan is to first determine the size of the pregnancy, to assess the presence and type of a possible multiple pregnancy, and then to exclude situations in which the NIPT test should not be performed. Since the NIPT test cannot detect structural developmental defects in a child, the objective of the ultrasound examination of very early developmental defects in the fetus is to exclude 10 severe developmental defects in the child.